Clinical trial
Abuse Potential of Buprenorphine and Naloxone in Non-Dependent Opioid Users
NCT00158236 · National Institute on Drug Abuse (NIDA), NIH · Completed
Key facts
| NCT number | NCT00158236 |
|---|---|
| Title | Abuse Potential of Buprenorphine and Naloxone in Non-Dependent Opioid Users |
| Official title | Effects of Buprenorphine/Naloxone in Non-Dependent Opioid Abusers |
| Lead sponsor | National Institute on Drug Abuse (NIDA), NIH |
| Status | Completed |
| Study type | Interventional |
| Conditions | Opioid-Related Disorders |
| Intervention type | Drug |
| Interventions | Buprenorphine, Buprenorphine and Naloxone, Hydromorphone |
| Enrollment | 7 |
| Start date | Jan 1, 1997 |
| Completion | Mar 1, 1998 |
| First posted | Sep 12, 2005 |
| Last update posted | Jan 12, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: